Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia
      QxMD      Google Scholar   
Citation:
Blood Adv vol 5 (2) 504-512
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
collection
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
10
Parents:
2035  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
Servier  
Grants:
U10CA180821, U10CA180882, U10CA98543, U10CA98413, U10CA180886 and U24CA196173 (C0G), U10CA180899, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233302, UG1CA233328, UG1CA233327, UG1CA233373, U10CA180820 (ECOG-ACRIN), U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                                               
Networks:
LAPS-AL002, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-NC010, MAINE, OH027   
Study
CALGB-10403
Multiple Studies, or Legacy Studies in Alliance Study:
COG-AALL0232
Phases:
2, 3
Keywords:
20, 24, Clinical Trials and Observations